177 related articles for article (PubMed ID: 36496167)
21. Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population.
Maglalang PD; Sinha J; Zimmerman K; McCann S; Edginton A; Hornik CP; Hornik CD; Muller WJ; Al-Uzri A; Meyer M; Chen JY; Anand R; Perrin EM; Gonzalez D;
Clin Pharmacokinet; 2024 Jun; 63(6):885-899. PubMed ID: 38814425
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Framework to Predict Maternal-Placental-Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach.
Werdan Romão MA; Pinto L; Cavalli RC; Duarte G; de Moraes NV; Abduljalil K; Moreira FL
J Clin Pharmacol; 2024 May; 64(5):568-577. PubMed ID: 38305718
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
24. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
[TBL] [Abstract][Full Text] [Related]
25. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
Abduljalil K; Pansari A; Jamei M
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
[TBL] [Abstract][Full Text] [Related]
26. Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids.
Krzyzanski W; Milad MA; Jobe AH; Jusko WJ
CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):668-680. PubMed ID: 36917704
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
28. Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.
Zheng L; Yang H; Dallmann A; Jiang X; Wang L; Hu W
Front Pharmacol; 2021; 12():793346. PubMed ID: 35126130
[TBL] [Abstract][Full Text] [Related]
29. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
[TBL] [Abstract][Full Text] [Related]
30. PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia.
Macente J; Nauwelaerts N; Russo FM; Deprest J; Allegaert K; Lammens B; Hernandes Bonan R; Turner JM; Kumar S; Diniz A; Martins FS; Annaert P
Front Pharmacol; 2023; 14():1068153. PubMed ID: 36998614
[TBL] [Abstract][Full Text] [Related]
31. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
32. Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.
Chaphekar N; Dodeja P; Shaik IH; Caritis S; Venkataramanan R
Front Pediatr; 2021; 9():733823. PubMed ID: 34805038
[TBL] [Abstract][Full Text] [Related]
33. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
Liu XI; Green DJ; van den Anker JN; Rakhmanina NY; Ahmadzia HK; Momper JD; Park K; Burckart GJ; Dallmann A
Front Pediatr; 2021; 9():723006. PubMed ID: 34733804
[No Abstract] [Full Text] [Related]
35. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19.
Liu XI; Dallmann A; Brooks K; Best BM; Clarke DF; Mirochnick M; van den Anker JN; Capparelli EV; Momper JD
CPT Pharmacometrics Syst Pharmacol; 2023 Feb; 12(2):148-153. PubMed ID: 36479969
[TBL] [Abstract][Full Text] [Related]
36. Physiologically-based pharmacokinetic models to predict drug exposure during pregnancy.
Ait-Chikh C; Page G; Thoreau V
Ann Pharm Fr; 2024 Mar; 82(2):236-242. PubMed ID: 37739215
[TBL] [Abstract][Full Text] [Related]
37. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
Anoshchenko O; Storelli F; Unadkat JD
Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
[TBL] [Abstract][Full Text] [Related]
38. Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate.
Mahdy WYB; Yamamoto K; Ito T; Fujiwara N; Fujioka K; Horai T; Otsuka I; Imafuku H; Omura T; Iijima K; Yano I
Clin Transl Sci; 2023 Apr; 16(4):618-630. PubMed ID: 36655374
[TBL] [Abstract][Full Text] [Related]
39. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
Garrity LC; Turner M; Standridge SM
Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683
[TBL] [Abstract][Full Text] [Related]
40. PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses.
Le Merdy M; Szeto KX; Perrier J; Bolger MB; Lukacova V
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
